Pennsylvania HB 1123: An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.

Status: Referred to Health (as of 2023-05-05)

State: Pennsylvania · Session: 2023-2024 · Bill: HB 1123

Sponsors: Dawn Keefer, Barbara Gleim, David Rowe, David Zimmerman, Joe Hamm, Joseph D'Orsie, Rob Kauffman, Robert Leadbeter

View Pennsylvania HB 1123 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.